Nanofiber Membrane Mimics Basement Membrane Properties
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro cell culture models fail to accurately mimic the physiological properties of the basement membrane, such as thickness, porosity, and fibrous composition, which are crucial for modeling physiological barriers like the blood-brain barrier, limiting their effectiveness in drug discovery and barrier dysfunction studies.
Innovation Solution
The development of nanofiber networks using the Spinneret-based Tunable Engineered Parameters (STEP) method, which creates ultra-thin, ultra-porous, and fibrous membranes that closely resemble the in vivo basement membrane, enabling close cell-cell contact and improved barrier modeling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional in vitro cell culture models are used, then ease of operation is maintained, but manufacturing precision of basement membrane properties (thickness, porosity, fibrous composition) deteriorates
Solution Approach 1:
The patent employs porous nanofiber membranes with controlled pore sizes (50-200 nm) and porosity (70-90%) to accurately replicate the basement membrane's filtration and transport properties. The porous structure enables precise control over molecular diffusion while maintaining physiological relevance, resolving the contradiction between manufacturing precision and ease of operation.
Solution Approach 2:
The invention utilizes parameter changes by controlling fiber diameter (50-500 nm), spacing (1-10 μm), and layer stacking to achieve desired membrane thickness (1-10 μm) and porosity. These adjustable parameters allow precise replication of in vivo basement membrane properties while maintaining fabrication feasibility through electrospinning technology.
2Manufacturing precision
If nanofiber networks with controlled orientation and spacing are created, then manufacturing precision of basement membrane structure is improved, but device complexity increases
Solution Approach 1:
The patent transitions from two-dimensional planar membranes to three-dimensional stacked nanofiber architectures. By stacking multiple nanofiber layers with controlled orientations (0°, 45°, 90°), the invention achieves complex basement membrane structures while leveraging the self-organizing properties of electrospun fibers to manage fabrication complexity.
Solution Approach 2:
The invention creates composite nanofiber structures by combining different fiber materials (e.g., PCL, PLGA, collagen) with varying diameters and orientations in stacked layers. This composite approach enables precise control over mechanical properties, porosity, and molecular diffusion while utilizing established electrospinning techniques to manage fabrication complexity.
3Manufacturing precision
If ultra-thin nanofiber membranes are used to mimic in vivo basement membrane thickness, then manufacturing precision of thickness is improved, but strength deteriorates
Solution Approach 1:
The patent applies local quality by varying fiber density, diameter, and orientation in different regions of the membrane. Thinner regions (1-5 μm) use higher fiber density for strength, while maintaining overall ultra-thin profile to match in vivo basement membrane thickness. This localized optimization resolves the contradiction between thickness precision and mechanical strength.
Solution Approach 2:
The invention employs composite materials combining biodegradable polymers (PCL, PLGA) with natural extracellular matrix components (collagen, fibronectin) to achieve both ultra-thin dimensions (1-10 μm) and adequate mechanical strength. The composite structure provides synergistic properties: synthetic fibers offer structural integrity while natural components provide biological functionality and enhanced strength-to-thickness ratio.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These nanofiber networks enhance trans-membrane molecular diffusion, support endothelial monolayer formation, and allow for more physiologically relevant cell-cell interactions, improving the realism of in vitro barrier models and facilitating drug discovery and barrier dysfunction studies.
Implementation Method 1
the nanofibers of each nanofiber layer cross-linked with nanofibers of an adjacent nanofiber layer
Implementation Method 2
These nanofiber networks enhance trans-membrane molecular diffusion
Data Source
AI summary
Various examples are provided related to nanofiber networks that can mimic in vivo physiology. In one example, a scaffold includes a nanofiber membrane extending across a scaffold opening. The nanofiber membrane can include a stack of nanofiber layers that include nanofibers disposed with a controlled orientation or direction and a controlled spacing. The nanofibers are cross-linked with nanofibers of an adjacent nanofiber layer. The scaffold can be incorporated into a transwell insert or plate. In another example, a microfluidic chip can include a first channel layer with a first fluid channel; a second channel layer comprising a second fluid channel; and a scaffold including a nanofiber membrane disposed between the first and second channel layers. The first and second channels cross each other.